The Cell Sorting Market is expected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% from 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
A number of factors such as technological advancements in cell sorters, growing adoption of cell sorter techniques in research activities, rising funding and investments for development of innovative cell sorting techniques, growing prevalence of HIV/AIDS and cancer, and launch of specific reagents for specific applications are fueling the growth of the cell sorting market. On the other hand, lack of awareness and technical knowledge regarding the use of cell sorters and high cost of instruments are some of the key factors limiting the growth of the global cell sorting market.
Cell sorters are utilized for separation and purification of various cell populations and sub-populations from a complex mixture of cells. A cell sorter separates the target cell population based on their intracellular or extracellular properties (such as protein or enzyme expression; cell size and shape; and presence of specific biomarkers). Key application of cell sorters is in research which includes fields such as immunological research, cancer and stem cell research, diseases diagnosis, and drug development.
The major players in the global Cell Sorting Market include Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sony Biotechnology Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly